4.7 Editorial Material

Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations

Related references

Note: Only part of the references are listed.
Article Medical Laboratory Technology

Therapeutic potential of low-dose IL-2 in immune thrombocytopenia: An analysis of 3 cases

Jiakui Zhang et al.

CYTOMETRY PART B-CLINICAL CYTOMETRY (2018)

Article Medicine, General & Internal

Alopecia areata

C. Herbert Pratt et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Article Medicine, Research & Experimental

Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia Areata

G. Conteduca et al.

CLINICAL AND EXPERIMENTAL MEDICINE (2014)

Letter Dermatology

Impaired inhibitory function of circulating CD4+CD25+ regulatory T cells in alopecia areata

Bong Seok Shin et al.

JOURNAL OF DERMATOLOGICAL SCIENCE (2013)

Article Endocrinology & Metabolism

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

Agnes Hartemann et al.

LANCET DIABETES & ENDOCRINOLOGY (2013)

Review Immunology

Standardizing immunophenotyping for the Human Immunology Project

Holden T. Maecker et al.

NATURE REVIEWS IMMUNOLOGY (2012)

Article Medicine, General & Internal

Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis

David Saadoun et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Medicine, General & Internal

Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

John Koreth et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Immunology

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

Weihong Liu et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2006)

Article Dermatology

Alopecia areata investigational assessment guidelines - Part II

EA Olsen et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)